PHARMACOLOGY Flashcards
Pharmcodynamics vs pharmakinetics
what drugs do to the body
what the body does to the drug
describe ion channel receptors
these are “gateways” into the cell membrane
they allow the selective passage of particular ions (think sodium, potassium, calcium etc)
they are fast and short acting
distributed widely
examples: nicotinic acetylcholine receptor, GABA A receptor
Ligand gated vs voltage gated receptors
Ligand gated –> responds to a particular ligand
voltage gated–> activated or deactivated by membrane potential changes
G coupled protein receptors
located on the cell membrane
need to be activated
once activated they transduce extracellular stimuli to intracellular stimuli
use ion channels or enzymes
most are olfactory
examples are muscarinic acetylcholine or adrenoreceptors
Kinase linked receptors
located on the cell membrane
transduce signals that regulate cell growth, differentiation, surival and migration
there are 3 subtypes
effects are very slow –> hours
example: insulin, growth factors, cytokine receptors
Nuclear receptors
they regulate gene expression
couples via DNA
very slow response
binds with a ligand and then goes under conformational change which recruits other proteins into a complex
example : corticosteroid (effect is slow as it promotes inflammation)
Define specificity
drugs with specific action, act directly on their receptor, one receptor one physiological response
no one drug currently available acts with complete specificity
Define selectivity
acts at one target and one target alone to produce a response
define affinity
extent to which a drug binds to receptors
drug with high affinity generally is associated with a low dose requirement
efficacy
ability of a ligand to bind to a receptor and produce a response
depends on the potency and interaction of the drug and the body
potency
describes the relationship between drug dose and magnitude of effect
full agonist
- Creates change at the site of action that mimics a physiological ligand
- Potency is determine by affinity and efficacy
- A full agonist has high efficacy
partial agonist
- Has both agonist and antagonist action
- Submaximal effect (low efficacy)
- Not able to produce a maximal physiological effect even if it binds to ALL of the receptors
- They can compete with full agonists for receptor occupancy and decrease the overall physiological response
inverse agonist
produces the oppposite biological response of the endogenous ligand
antagonist
- A drug which reduces the physiological response of another drug (decreases the efficacy of another ligand)
- The effect of one drug is diminished or completely abolished in the presence of another
- Binds at the site of action but does not produce the conformation change required to produce a response
- It also blocks an agonist from binding
competitive antagonism
- Some can be reversed or displaced by increasing the dose of the agonist (this is known as surmountable antagonism) ie it can be overcome
competitive irreversible antagonism
- Usually bind to the same site as the agonist however is not as readily displaced from the binding site like a competitive antagonist
- Compete for the same receptor site
- Modifies the receptor and prevents the release of the antagonist and binding of agonist
- Can be months or weeks
- This is due to a covalent bond that is formed between the antagonist and receptor which in essence reduces the amount of receptors that any circulating agonist can bind to
- Any agonist present is going to exert a lower maximum response
- Adding more agonist is not going to be able to produce maximal response
competitive reversible
- Competes at the same site as the agonist
- Example is naloxone, ipratropium bromide
- Adding more agonist can displace the antagonist and produce the maximal response
non competitive antagonism
- Antagonist targets a site that is different to the primary ligand binding site
- There are primary AND alternative sites on receptors
- So the focus is on the alternate site
- Doesn’t stop the agonist from binding
- But interferes with secondary chemical messengers within the cell that the agonist depends on to generate a response
physiological antagonism
- Binding of two ligands causing opposing physiological effects
- Results when medications that do not bind to the same receptor as the endogenous agonist produce an effect that is opposite to the agonist effect
eg –> histamine in anaphylaxis and adrenaline
pharmacokinetic antagonism
- Increase or decreases the activity of another ligand or drug
chemical antagonism
- Results when drugs do not interact at the agonist receptor, rather reduce the concentration of an agonist by forming a chemical complex (chelating agents)
- Crushing medications separately so they don’t bind together and alters their structures and effects
desensitisation / tachyphylaxis
the effect of the drug gradually diminishes when it is given repeatedly or continuously
usually develops over a few minutes
can result in increasing doses of a drug required to achieve the same biological effect, which in turn can lead to greater desensitisation
tolerance
gradual decrease in responsiveness to a drug
takes hours days or weeks to develop
happens after repeated doses
mechanisms for desensitisation and tolerance
- Chronic exposure to agonist = decrease number of receptors
- Downregulation reduced synthesis of new receptors
- Sequestration or internalisation degradation of pre existing receptors through endocytosis
refractoriness and resistance
- Used to describe a lack of therapeutic responsiveness to a drug
- Describes the loss of effectiveness of antimicrobial or antitumor cells
- Resistant bacterial cells adopt different survival mechanisms such as target changing through mutation